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Abstract
Background: The metabolic syndrome (MetS) concept is widely used in public health and clinical settings without an 
agreed pathophysiology. We have re-examined the MetS in terms of body fuels, so as to provide a coherent cross-
cultural pathogenesis.
Methods: National Health and Nutrition Examination Survey (NHANES 2001-2) with n = 2254 and Taiwanese National 
Health Interview Survey (NHIS) sub-set for hypertension, hyperglycemia and hyperlipidemia assessment (TwSHHH 
2002), n = 5786, were used to compare different ethnicities according to NCEP-ATPIII (NCEP-tw) criteria for METS. 
Exploratory factor analysis (EFA) using principal components (PC) was employed to differentiate and unify MetS 
components across four ethnicities, gender, age-strata, and urban-rural settings.
Results: The first two factors from the PC analysis (PCA) accounted for from 55.2% (non-Hispanic white) to 63.7% 
(Taiwanese) of the variance. Rotated factor loadings showed that the six MetS components provided three clusters: the 
impaired energy regulation (IER) components (waist circumference, WC, fasting triglycerides, TG, and fasting plasma 
glucose, FPG), systolic and diastolic blood pressures (BPs), and HDL-cholesterol, where the IER components accounted 
for 25-26% of total variance of MetS components. For the three US ethnic subgroups, factor 1 was mainly determined 
by IER and HDL-cholesterol, and factor 2 was related to the BP components. For Taiwanese, IER was determinant for 
both factors, and BPs and HDL-cholesterol were related to factors 1 and 2 respectively.
Conclusions: There is a MetS core which unifies populations. It comprises WC, TG and FPG as a core, IER, which may be 
expressed and modulated in various second order ways.
Background
The metabolic syndrome (MetS) was conceptualized on
the basis that a cluster of metabolic phenomena could be
observed in those prone to cardiovascular disease ahead
of frank diabetes. It combined features of possible patho-
genesis with risk evaluation. Its definition has been in
evolution, but those currently used include that of the
International Diabetes Federation (IDF) in 2005 [1,2] and
the joint NHLB (National Heart Lung and Blood) Insti-
tute/AHA (American Heart Association) definition of
2004 [3], based on the NCEP-ATP III (National Choles-
terol Education Program-Adult Treatment Panel III) [4].
The latter has also been modified in Taiwan as NCEP-tw
[5]. Both clinical and public health utility have been in
mind. However, a 'syndrome' is usually the way in which
clinicians articulate what they observe in patients as a set
of symptoms and signs, but where etiology or pathogene-
sis is uncertain. The field of enquiry into the MetS has
grown rapidly without settling the matter of the syn-
drome being a coherent disorder or disease for clinicians
or, for public health workers, an entity with 'inputs' and
scope for prevention and with 'outputs' in monitoring and
surveillance. Despite these limitations, Japanese health
authorities have recently embarked on a national pro-
gram to encourage citizens to have their MetS assessed
and to engage in rigorous efforts to 'normalize' it. Unfor-
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tunately, definitions differ in different places by 'cut-off'
points rather than continua; the basis of these 'cut-offs' is
rarely on the basis of all-cause morbidity or mortality;
and the relationship of measurements like waist circum-
ference to underlying anatomy not well-characterized.
Interestingly, in Japan, imaging techniques have allowed
waist circumference to be related to intra-abdominal fat
so that the usual gender acceptance of a greater girth for
men than women is reversed [6].
There have been efforts to create a unified explanatory
model for this syndrome. The best known of these is that
the MetS is a disorder of insulin sensitivity i.e. basically
'insulin resistance' and its sequelae, however it may be
caused, as suggested by the IDF [1].
It could be argued that the anatomico-physiological
basis of the syndrome is in the splanchnic region [7] with
disordered energy metabolism [8]. This region has a por-
tal circulation which links the venous drainage of the gut,
omental fat, pancreas and spleen to the liver which, in
turn, drains into the systemic venous system (the inferior
vena cava). It constitutes the metabolic focus for regula-
tion of energy balance, albeit with neuro-endocrine con-
trol, and accounts for some of the MetS variables while
other variables are a consequence of this disorder [9].
Omental fat (which contributes to abdominal or waist
circumference) represents a very metabolically active site
for fat storage with a free fatty acid (FFA) flux which acts
a regulator of hepatic gluconeogenesis [10] and of hepatic
triglyceride (TG) and its very low density lipoprotein
(VLDL) TG synthesis [11]. The major function of VLDL
TG is to transport energy to peripheral tissues [12]. FFA
play a role at the periphery as well in regulating glucose
uptake and may be as potent as insulin, but in the reverse
direction [13]. Thus, waist circumference as a surrogate
for omental fat and FFA flux, serum triglycerides and
fasting glucose (representing nocturnal hepatic gluconeo-
genesis) could serve as a composite index of energy
metabolism or its disorders. There is, nevertheless,
debate about whether waist circumference adds any addi-
tional value to the assessment of body fatness by use of
BMI (body mass index) [14], yet the distribution of body
fat is relevant to the pathogenesis of various clinical dis-
orders, notably diabetes and cardiovascular disease and,
in turn, to mortality although under review by some
authors [15]. In the evaluation of the pathology of fat dis-
tribution, it is a consideration as to what extent WC rep-
resents visceral (elemental) fat [16], which is the
metabolically relevant fat in the splanchnic region.
The MetS and energy dysmetabolism are modulated by
a number of factors including the psycho-social [9,17]
and environmental; locality [18]; food systems; physical
activity patterns, biological rhythms (sleep, leisure and
work, and sunlight exposure which affects vitamin D sta-
tus) and pollutants [12]. Their relevant consequences
include inflammatory [19-21], and vascular pathways
[21].
There are often striking differences in the presentations
of the MetS in Western and Eastern populations. We have
taken advantage of such differences between the USA and
T aiwan to test for hypothesis generation. In the case of
the USA, we have used the National Health and Examina-
tion Survey (NHANES) of 2001-2002 data [22] and in the
case of Taiwan, we have used a sub-set of the Taiwanese
Health Survey, the "Taiwan Three High Prevalence Sur-
vey on Hypertension, Hyperglycemia, and Hyperlipi-
demia" (TwSHHH) of 2002 [23].
Exploratory factor analysis (EFA) has been used for
hypothesis generation. It is a multivariate correlation
method to reduce a number of inter-correlated variables
into smaller sets of factors with less or no association; it
has been applied to study the clustering of metabolic
abnormalities that contribute to the metabolic syndrome
[18,20,24,25]. Here we have used EFA to differentiate
major factors derived from the six components of the
MetS as continuous variables. A single factor structure or
multi-factorial structure can suggest a common or het-
erogeneous pathogenetic background, respectively, as
underlying the clinical manifestations of the syndrome
[25]. We sought invariance in clustering patterns of the
estimated factor loadings (or communalities) across the
four ethnic subgroups. Specifically, we tested the proposi-
tion that there is a core to the metabolic syndrome which
reflects energy dysregulation. This would manifest as at
least one factor which could describe energy storage and
transport, possibly by way of abdominal fatness for stor-
age and as a dynamic source of FFA for energy transport
along with both fasting glucose and triglycerides as sub-
strates too.
Methods
Subjects and measurements
The study was approved by the Institutional Review
Board (ethics committee) of the NHRI (National Health
Research Institutes) of Taiwan.
Two datasets, one from each of Taiwan and the US were
used for this study. The Taiwan data came from the Tai-
w a n e s e  S u r v e y  o n  H y p e r t e n s i o n ,  H y p e r g l y c e m i a ,  a n d
Hyperlipidemia (TwSHHH) in year 2002 [23], a subset of
the national health interview survey (NHIS) conducted in
2001 [26]. Community-based subjects, aged 17-91 years
were identified through the national household registry.
There were no exclusions on health grounds, but residen-
tial institutions were not included in the sampling frame
as the study was community based. However, those with
missing or biologically implausible data were not
included in the analysis. NHIS incorporated a multistage
stratified systematic sampling scheme. It first divided 359
townships/districts of Taiwan into seven strata accordingWahlqvist et al. BMC Endocrine Disorders 2010, 10:11
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to their geographical location and degree of urbanization
or rural location. Townships or districts in each stratum
were selected with a selection probability proportional to
their size (PPS). In each selected township/district, lins
(the smallest administrative unit) were selected with PPS.
Four households were selected randomly from each
selected lin, with each member of these households to be
interviewed. The response rate for households was 91.1%,
and it was 94.2% for individuals [24]. The design resulted
in an equal probability sample. No sampling weights were
required in the estimation. Anthropometric measure-
ments were taken. Subjects were asked to avoid walking,
running or lifting heavy things 30 minutes before blood
pressures were measured. After they sat down for mea-
suring blood pressures, they were asked to rest for 5 to 10
minutes. Two blood pressure readings were made with a
calibrated mercury sphygmomanometer in the sitting
position using a binaural stethoscope and simultaneous
readings by 2 observers who recorded the findings inde-
pendently. Readings were accepted only if they did not
differ by more than 2 mmHg If the 2 measurements sepa-
rated in time differed by more than 10 mmHg, a third
reading was obtained. The average of the closest 2 read-
ings was used. Subjects were instructed to fast for 8 hours
o r  m o r e  b e f o r e  t h e  b l o o d  s a m p l e s  w e r e  t a k e n .  N a F
plasma was collected for fasting glucose analysis, and
serum was collected for measurements of lipids. Blood
samples were transported at -10°C in dry ice to the cen-
tral laboratory, stored at -20°C and analyzed within 2
weeks. Fasting plasma glucose (FPG) was analyzed by the
glucose oxidase method using an automated system (Vit-
ros 550/750, Ortho-Clinical Diagnostic Inc., Johnson and
Johnson Company, Rochester, NY, USA).
The other dataset was the NHANES which comes from
interviews, examinations, and laboratory tests based on
blood and urine samples http://www.cdc.gov/nchs/
nhanes.htm[22]. The 2001-2002 data were used for this
study. Subjects were 18-85 years old, community-based,
irrespective of health status, similar to the Taiwanese
sample. Anthropometric, blood pressure recording,
blood sampling and analyte measurements were subject
to similar standardisation as used in Taiwan. In the case
of BP, three and sometimes 4 BP determinations (systolic
and diastolic) were taken in a mobile examination center
(MEC) and during home examinations on all eligible indi-
viduals using a mercury sphygmomanometer; two physi-
cians (MEC setting) and 2 health technologists (Home
Examination setting) were trained to collect NHANES BP
data [22].
As with the Taiwanese sample, when data were missing,
or biologically implausible, the subject was not included
in the analyses.
When examining the relationships between measure-
ments, sampling weights were not necessary
Statistical Analysis
Descriptive statistics, such as mean and standard devia-
tion, were used to present the characteristics of the study
populations. An EFA using the method of principal com-
ponents [27] was applied to assess the factor structure of
the six components: WC, FPG, TG, HDL, SBP, and DBP
of the metabolic syndrome for all four ethnic groups: Tai-
wanese, non-Hispanic white, non-Hispanic black, and
Mexican-American. Among the first two factors from
principal component analysis (PCA), relative proportions
of the total variance of the six standardized MetS compo-
nents were estimated using the procedure PROC FAC-
TOR from SAS software (SAS version 9.1. 2002; SAS
Institute, Cary NC, USA). The factor loadings were then
rotated using the varimax criterion for the clustering pat-
terns of the six components from the first two factors for
each of the ethnic groups. To assess the sensitivity of the
estimated proportions, for each of the four ethnic groups,
the EFA procedure was applied repeatedly for their com-
munalities in each of the one thousand resampled data-
sets by bootstrapping [28]. The 95% confidence interval
(CI) of the clustered components was then obtained by
taking the 25th and 975th millile of the sorted added-up
communalities of the corresponding clustered compo-
nents among one thousand bootstrapped datasets.
Results
Descriptive statistics
The average ages and the metabolic components for the
several ethnic groups are presented in Table 1. The aver-
age age of the non-Hispanic whites was 50.3 ± 20 years,
whereas those of other ethnic groups was around 40 years
old. Taiwanese had lower values for most of the compo-
nents, except diastolic blood pressure and HDL (which
were higher). That resulted in lower prevalence of abnor-
mality for each component as well as for the metabolic
syndrome than in other ethnic groups (Table 2). It is also
noteworthy that Taiwanese subjects were the shortest
and had the lowest Body Mass Indices (BMIs).
In regard to urbanization, the analysis was only possible
for Taiwanese (Table 1). There were few biologically
meaningful differences in the subject characteristics,
although, large sample sizes allowed significance to be
seen with some minor differences. In general, rural sub-
jects had less satisfactory MetS related biological charac-
teristics. Medication use for hypertension, diabetes and
hyerlipidaemia did not differ between the 2 settings or by
gender.
We have not shown the findings for physical activity or
alcohol consumption because of the high frequencies
(>20%) of missing values in NHANES. However, in Tai-
wan, this was not the case (missing values < 5%).
Pearson correlations are shown in Table 3. Although
not a MetS component, we have included BMI as well asWahlqvist et al. BMC Endocrine Disorders 2010, 10:11
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Table 1: Comparisons of the MetS components of Taiwanese (urban and rural) and the different US ethnic groups
Variables Ethnic Groups P-value†
Taiwanese US non-Hispanic 
whites
US non-Hispanic 
Black
US Mexican 
Americans
Urban Rural All
All N = 3650 N = 2136 N = 5786 N = 1248 N = 457 N = 549
Age (years) 42.3 ± 15.4 42.9 ± 16.4 42.5 ± 15.7 50.3 ± 20.0 40.8 ± 18.0 40.5 ± 18.8 < .0001
WC (cm) 79.4 ± 11.3 79.9 ± 11.2 79.6 ± 11.3 96.7 ± 15.2 94.3 ± 17.3 95.4 ± 14.2 < .0001
Glucose (mg/dl) 92.5 ± 25.6 95.5 ± 29.1 ** 93.6 ± 27.0 102.4 ± 29.0 101.7 ± 45.1 106.7 ± 37.9 < .0001
Triglycerides(mg/dl) 123.0 ± 79.4 132.1 ± 91.1 ** 126.3 ± 84.0 157.4 ± 178.8 106.1 ± 69.8 156.3 ± 118.4 < .0001
HDL (mg/dl) 56.1 ± 14.8 54.5 ± 14.8 ** 55.5 ± 14.8 52.5 ± 16.2 53.7 ± 16.3 49.4 ± 13.8 < .0001
LDL (mg/dl) 114.7 ± 27.0 116.4 ± 26.9 ** 115.3 ± 27.0 122.0 ± 35.6 117.6 ± 36.8 115.8 ± 33.1 < .0001
Total Cholesterol(mg/dl) 182.7 ± 36.8 183.5 ± 36.5 183.0 ± 36.7 204.1 ± 44.1 192.4 ± 43.0 195.1 ± 41.0 < .0001
SBP (mm Hg) 113.7 ± 17.4 116.4 ± 17.6 ** 114.7 ± 17.5 124.3 ± 20.2 125.3 ± 20.6 120.2 ± 18.9 < .0001
DBP (mm Hg) 74.5 ± 11.2 75.3 ± 11.2 ** 74.8 ± 11.2 71.1 ± 11.4 73.5 ± 13.5 68.8 ± 11.4 < .0001
BMI (kg/m2) 23.1 ± 3.5. 23.3 ± 3.7 ** 23.1 ± 3.6. 27.7 ± 5.9 28.4 ± 7.0 28.0 ± 5.7 < .0001
Weight (Kg) 61.5 ± 11.5 61.7 ± 11.7 61.5 ± 11.6 79.6 ± 19.0 82.2 ± 20.2 75.1 ± 17.5 < .0001
Height (cm) 162.9 ± 8.1 162.3 ± 7.9 ** 162.6 ± 8.0 169.4 ± 10.0 170.4 ± 9.8 163.7 ± 9.1 < .0001
HT drug (%) 7.5 8.1 7.7 12.3 5.9 6.0 < .0001
DM drug (%) 3.1 3.3 3.2 5.5 8.1 9.3 < .0001
Lipid drug (%) 1.7 1.6 1.7 14.9 7.7 8.9 < .0001
Current smoker ¥(%) 18.8 22.1 ** 20.0 22.1 26.5 21.1 0.0129
Males N = 1746 N = 1081 N = 2827 N = 602 N = 226 N = 266
Age (years) 42.5 ± 16.0 44.2 ± 17.0 ** 43.1 ± 16.4 50.5 ± 19.3 40.5 ± 17.4 40.8 ± 19.1 < .0001
WC (cm) 84.2 ± 10.7 84.4 ± 10.2 84.3 ± 10.5 100.6 ± 14.0 92.2 ± 16.6 96.6 ± 13.3 < .0001
Glucose (mg/dl) 93.5 ± 27.4 96.5 ± 30.0 ** 94.6 ± 28.5 106.8 ± 33.9 102.8 ± 46.8 109.9 ± 35.0 < .0001
Triglycerides(mg/dl) 139.1 ± 88.5 151.4 ± 103.6 ** 143.8 ± 94.7 172.2 ± 238.3 111.0 ± 78.9 162.4 ± 138.1 < .0001
HDL (mg/dl) 52.1 ± 14.4 50.6 ± 14.7 ** 51.5 ± 14.6 45.5 ± 12.0 50.9 ± 14.7 44.0 ± 10.7 < .0001
LDL (mg/dl) 116.8 ± 26.7 117.2 ± 26.6 113.7 ± 27.1 122.4 ± 36.0 117.1 ± 36.3 119.2 ± 34.2 0.0010
Total Cholesterol (mg/dl) 182.6 ± 35.9 182.4 ± 36.4 183.4 ± 37.2 199.7 ± 46.3 190.2 ± 43.6 192.9 ± 40.1 < .0001
SBP (mm Hg) 117.5 ± 15.9 120.7 ± 16.7 ** 118.9 ± 16.3 124.7 ± 17.0 127.3 ± 20.0 123.0 ± 16.5 < .0001
DBP (mm Hg) 77.7 ± 10.7 78.3 ± 11.1 77.9 ± 10.9 73.0 ± 11.0 76.0 ± 13.6 69.7 ± 12.1 < .0001
BMI (kg/m2) 23.7 ± 3.4 23.9 ± 3.4 23.7 ± 3.4 27.9 ± 5.4 26.6 ± 5.7 27.6 ± 4.9 < .0001
Weight (Kg) 67.7 ± 10.8 67.4 ± 10.7 67.6 ± 10.7 87.0 ± 17.8 84.2 ± 19.3 80.0 ± 16.6 < .0001
Height (cm) 168.9 ± 6.1 167.8 ± 6.0 ** 168.4 ± 6.1 176.7 ± 7.4 177.8 ± 6.9 170.0 ± 7.2 < .0001
HT drug (%) 7.6 9.2 8.2 12.5 6.6 5.6 0.0011
DM drug (%) 3.6 3.6 3.6 6.1 7.5 9.0 < .0001
Lipid drug (%) 1.7 1.6 1.7 14.8 8.4 7.5 < .0001
Current smoker ¥(%) 36.1 41.4 38.2 24.6 31.6 27.1 < .0001Wahlqvist et al. BMC Endocrine Disorders 2010, 10:11
http://www.biomedcentral.com/1472-6823/10/11
Page 5 of 16
WC because of the interest in the intercorrelation
between BMI and WC.
The correlation between BMI and WC is less in Tai-
wanese (r = 0.75) than in US ethnic groups (r = 0.88, 0.91
and 0.90 for Non-Hispanic White: NHW; Non-Hispanic
Blacks: NHB and Mexican American: MA, respectively).
With the exception of blood pressure, the remaining cor-
relations between the metabolic syndrome components
are similar for the various ethnic groups.
Exploratory factor analysis
For both the TW3HHH and NHANES datasets, all the
distributions of the six components were skewed to the
left. Therefore, a log-transformation was applied to each
of the six components before analysis, so that the compo-
nent variables were approximately normally distributed.
Figure 1a-1d presents the score plots from PCA after
rotation of the ethnic groups separately. The data points
with similar factor structures were closely located as a
cluster whereas those with divergent patterns were
located further apart. They were classified according to
the position of the corresponding coordinates with
respect to the factor axis after rotation. As shown in Fig-
ure 1a-1d, for all the four ethnicity groups, the score plot
shows that the data points were clustered into three
groups: IER (Impaired Energy Regulation) components
(WC, FPG, TG), systolic and diastolic blood pressures
(SBP, DBP), and HDL-cholesterol. For the three US ethnic
subgroups, factor 1 was mainly determined by the IER
components and low HDL-cholesterol, and factor 2 was
related to the BPs components; whereas for Taiwanese
the IER components were determinant for both factors 1
and 2, and hypertension and HDL-cholesterol were
related to factors 1 and 2 respectively (Figure 1e).
In the case of Taiwan, the IER cluster was closer to the
BP cluster than in the US ethnic groups.
Figure 2 illustrates the total variance explained by the
first two factors and relative variance compositions of the
IER components, BPs, and HDL-cholesterol across the
four ethnic groups, with specific percentages given in
Table 4. The first two factors accounted for 55.2% (Cauca-
sian) to 63.7% (Taiwanese) of the total variances. As
shown in figure 2, the proportions of variance explained
by the IER components were relatively homogeneous for
different ethnic subgroups, with absolute percentages
Females N = 1904 N = 1055 N = 2959 N = 646 N = 231 N = 283
Age (years) 42.1 ± 14.8 41.6 ± 15.6 41.9 ± 15.0 50.1 ± 20.6 41.1 ± 18.9 40.2 ± 18.5 < .0001
WC (cm) 74.9 ± 9.9 75.3 ± 10.2 75.0 ± 10.0 93.0 ± 15.4 96.2 ± 17.8 94.2 ± 14.9 < .0001
Glucose (mg/dl) 91.5 ± 23.8 94.4 ± 28.0 ** 92.6 ± 25.4 98.3 ± 22.9 100.5 ± 43.4 103.8 ± 40.2 < .0001
Triglycerides (mg/dl) 108.2 ± 66.6 112.3 ± 70.9 109.7 ± 68.2 143.6 ± 92.1 101.3 ± 59.4 150.6 ± 96.1 < .0001
HDL (mg/dl) 59.7 ± 14.2 58.5 ± 13.7 ** 59.2 ± 14.0 59.0 ± 17.0 56.5 ± 17.4 54.4 ± 14.4 < .0001
LDL (mg/dl) 112.7 ± 27.1 115.6 ± 27.1 ** 117.0 ± 26.7 121.6 ± 35.2 118.1 ± 37.4 112.7 ± 31.6 < .0001
Total Cholesterol (mg/dl) 182.8 ± 37.6 184.6 ± 36.6 182.5 ± 36.1 208.1 ± 41.7 194.5 ± 42.5 197.2 ± 41.7 < .0001
SBP (mm Hg) 110.3 ± 17.9 112.1 ± 17.5 ** 110.9 ± 17.8 123.9 ± 22.7 123.3 ± 21.0 117.6 ± 20.6 < .0001
DBP (mm Hg) 71.7 ± 10.8 72.3 ± 10.5 71.9 ± 10.7 69.2 ± 11.4 71.0 ± 13.0 67.9 ± 10.8 < .0001
BMI (kg/m2) 22.5 ± 3.5 22.8 ± 4.0 22.6 ± 3.7 27.4 ± 6.4 30.0 ± 7.8 28.3 ± 6.3 < .0001
Weight (Kg) 55.7 ± 8.9 55.9 ± 9.8 55.8 ± 9.2 72.6 ± 17.4 80.1 ± 20.8 70.4 ± 17.0 < .0001
Height (cm) 157.3 ± 5.3 156.7 ± 5.2 ** 157.1 ± 5.3 162.6 ± 6.8 163.2 ± 6.3 157.7 ± 6.2 < .0001
HT drug (%) 7.4 7.0 7.2 12.2 5.2 6.4 < .0001
DM drug (%) 2.7 3.0 2.8 5.0 8.7 9.5 < .0001
Lipid drug (%) 1.7 1.7 1.7 15.0 6.9 10.2 < .0001
Current smoker ¥(%) 3.0 2.2 2.7 19.7 21.7 15.5 < .0001
WC: waist circumference; HDL: high-density lipoprotein; LDL: low-density lipoprotein; SBP: systolic blood pressure; DBP: diastolic blood pressure;
BMI: body mass index.
† At significant level α = 0.05, p-value < 0.05 was used for ANOVA for differences in means and chi-square test for proportions among four different 
ethnic groups; p-value < 0.05** was used for two-sample t-test were used for comparing means and proportions between urban and rural 
Taiwanese.
‡ LDL is calculated from measured values of total cholesterol, triglycerides, and HDL according to the Friedewald calculation for US NHANES 2001-
2002: [LDL] = [total cholesterol] - [HDL] - [triglycerides/5] where all values are expressed in mg/dL. The calculation is valid for triglycerides less 
than or equal to 400 mg/dL.
¥ Current smokers were considered to subjects who have a life-time smoking experience of ≥ 100 cigarettes and currently smoke.
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ranging from 24.6% (Taiwanese) to 25.9% (non-Hispanic
black) and relative percentages ranging from 38.5% to
45.8%. However, the proportions of variance explained by
BPs and HDL-cholesterol were somewhat heterogeneous.
For example, the absolute percentages of hypertension
ranged between 20.1% (non-Hispanic white) and 26.8%
(Taiwanese). The invariance pattern of the IER compo-
nents was similar across the four ethnic subgroups when
stratified by gender. However, males had slightly lower
proportions of the IER components than females for all
the four ethnic groups.
In contrast, females tended to have lower communali-
ties in BPs than males except for Mexican-Americans, for
whom the females had substantially higher communality.
The 95% CIs obtained from bootstrap resamplings were
reasonably narrow and homogeneous for all the clustered
components across the four ethnic groups as well as the
males and females separately, with Taiwanese having the
narrowest bounds possibly due to the relatively large
sample size (Figure 3, Table 4).
Table 5 shows the subject comparisons for Taiwanese
by age strata (< 35, 35-65, and. ≥ 65), by gender and by
urban-rural locality. There are generally unfavourable dif-
ferences for younger and middle-aged rural compared
with urban subject, but not for elderly people. Medica-
tion usage is greater for the elderly, whether urban or
rural, as expected. Smoking is markedly less for women
than men in all age groups and in both urban and rural
settings. When considered by gender, there are no differ-
ences between urban and rural dwellers for smoking.
In Figure 3 we show the absolute cumulative variances
(Communality Estimates) for MetS component clusters
obtained from factor analysis where the cut-points for
factor loadings were 0.40. These correspond to the age,
gender and locality settings represented in Table 5. Two
MetS clusters (WC, FPG, T G and SBP with DBP) and
HDL together explain about 50-60% of the communality
estimates for the MetS, and the IER cluster explains about
25%, as these clusters do when the analyses are by ethnic-
ity as shown in Table 4 and in figures 1 and 2. The excep-
tion is that of urban women where 3 factors emerge (data
not shown) and the IER cluster does so more strongly
(32.5% of the communality estimates compared with
25.8% for the rural women); in the case of urban women,
the same 2 collective clusters and HDL explain more than
70% of the communality estimates for the MetS. These
findings indicate that an IER core of the MetS compo-
nents exists irrespective of ethnicity, gender, age or local-
ity, although more pronounced for older urban women.
The factor analysis for elderly Taiwanese (≥ 65 y) is sim-
ilar to a factor analysis of the MetS in elderly Swedes (≥ 75
y) [29] where a core of WC, FPG, TG and Inverse HDL
constituted a Metabolic Factor and, with a BP Factor,
accounted for most of the variance (data not shown).
Although the communality estimates are not available to
us for the Swedish elderly who were located in a provin-
cial setting, we can say that elderly men in Sweden and
Taiwan have comparable factor loadings for the various
MetS components [29] Rural Taiwanese women, but not
Urban Taiwanese women, had a Metabolic factor and a
BP factor like provincial Swedish women.
Discussion
Consistent component core
This study utilized factor analysis to discover a consistent
component core as a likely core of the metabolic syn-
drome. We found a similar pattern in different ethnic
groups. It confirms our hypothesis about IER. Wijndaele
et al. [30] also used factor analysis to construct scores for
the metabolic syndrome. They obtained two factors
based on the components of the metabolic syndrome.
They then multiplied each component by factor loading
and weighed the sum by the relative contribution in the
proportion of variance explained by each factor. They
called it the "continuous metabolic syndrome risk score".
Later on, they used this score as a dependent variable and
investigated the effects of sedentary behaviors and leisure
time physical activity on it [31]. They did not investigate
the clustering nature of each component in detail.
Instead, they used the score directly. We also obtained
two factors for different ethnic groups. With an in depth
examination of the clustering nature of each component,
we found that there was a component aggregate in the
metabolic syndrome, which we have referred to as IER, a
core to the conventional MetS.
Öhrvik et al. [29] have explored factor analysis of the
MetS in an elderly Swedish population. They used the
reciprocal of HDL and log transformation of FPG and TG
and found two factors. A metabolic factor with our three
IER components and a BP factor in men and women. We
have analyzed the elderly Taiwanese data in the same way
and find similar results for men, and for rural women, but
not for urban women, who seem to have enhanced the
'IER' core seen in the younger population in its various
settings and have 3 rather than 2 factors (Figure 3) [29].
We find this age, gender and urban-rural differential of
interest since it may indicate a biological survival strategy
or, conversely, be a signal of potential demise, or just
relate to ageing in some way, depending on what comes
first and its predictive power for future health. This is a
question we expect to pursue in future data-linkage stud-
ies on morbidity and mortality outcomes.
At present we can say that ethnicity, and urbanisation
and, with the exception of elderly women in urban set-
tings, display a common core to the MetS which could
reflect IER. Where this does not apply may provide clues
to the pathogenesis and consequences of the MetS. An
example of this could be the report of Malan et al (2008)Wahlqvist et al. BMC Endocrine Disorders 2010, 10:11
http://www.biomedcentral.com/1472-6823/10/11
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[18] that the expression of the MetS syndrome by setting
(urban-rural) may depend on an individual's coping skills.
Unifying capacity of IER
Various attempts have been made to provide a mechanis-
tic construct on the many observations of the MetS clus-
ter of 6 components with insulin resistance being the
earliest and most preferred. For example, Alberti and col-
leagues recommended one single set of cut points for all
components except waist circumference [32]. Neverthe-
less, it has begged the question as to what is fundamen-
tally going on in people who manifest it, especially in
regard to its genotypic, phenotypic or, more recently, its
epigenetic basis. By the conceptual separation of IER
from the rest of the MetS, it is possible to consider its
Table 2: Weighted prevalence of MetS and component risk factors by sex and ethnicity for Taiwan 2002TwHHH and US 
NHANES 2001-2002
Ethnic Groups
Variables Taiwanese Non-Hispanic White Non-Hispanic Black Mexican- American
All (N = 5786) (N = 1077) (N = 381) (N = 461)
Abdominal Obesity (NCEP)* ¶ 29.8 48.5 46.9 43.1
Abdominal Obesity (IDF)§ ¶ 29.8 71.1 62.6 67.8
High Blood Pressure** 29.8 39.7 45.8 21.7
Low HDL† 22.8 33.7 32.0 41.2
High Glucose‡ 10.0 36.2 26.7 42.3
High Triglycerides¥ 26.3 34.9 18.8 34.8
NCEP MetS 10.8 34.8 28.4 32.8
IDF MetS 8.6 39.9 31.5 35.2
Males (N = 2827) (N = 555) (N = 196) (N = 249)
Abdominal Obesity (NCEP)* ¶ 29.2 39.9 29.3 34.0
Abdominal Obesity (IDF) § ¶ 29.2 67.1 49.6 63.0
High Blood Pressure** 35.2 41.9 55.3 38.5
Low HDL† 21.1 32.9 21.7 34.6
High Glucose‡ 10.5 46.1 31.3 60.6
High Triglycerides¥ 33.2 39.0 23.5 43.0
NCEP MetS 11.2 36.7 26.6 39.5
IDF MetS 9.2 44.6 29.1 42.5
Females (N = 2959) (N = 522) (N = 185) (N = 212)
Abdominal Obesity (NCEP)* ¶ 31.2 51.8 67.5 66.0
Abdominal Obesity (IDF) § ¶ 31.2 72.2 83.2 86.1
High Blood Pressure** 25.0 36.1 50.3 32.4
Low HDL† 24.9 35.1 44.1 50.0
High Glucose‡ 9.7 25.3 32.0 41.1
High Triglycerides¥ 20.5 27.8 16.6 31.6
NCEP MetS 11.0 30.0 37.5 45.7
IDF MetS 8.3 33.2 41.1 47.0
Abbreviations are as footnoted in Table 1.
¶ Males waist circumference ≥90 cm; females waist circumference ≥80 cm for Taiwanese population;
* NCEP: males waist circumference > 102 cm; female waist circumference > 88 cm;
§ IDF: males waist circumference ≥94 cm; females waist circumference ≥80 cm
** Systolic ≥ 130 mmHg or diastolic ≥85 mmHg or on anti-hypertensive medication
† Males fasting HDL < 40 mg/dL; females fasting HDL < 50 mg/dL
‡ Fasting glucose ≥110 mg/dL or on glucose-lowering medication
¥ Triglycerides ≥150 (mg/dl).Wahlqvist et al. BMC Endocrine Disorders 2010, 10:11
http://www.biomedcentral.com/1472-6823/10/11
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Table 3: Pearson Correlations of the MetS Components for Taiwanese, Non- Hispanic White, Non-Hispanic Blacks and 
Mexican-Americans
Variable Ethnic Groups WC HDL TG FPG SBP DBP
BMI Taiwanese 0.75* -0.20* 0.41* 0.23* 0.36* 0.39*
Rural 0.75* -0.28* 0.47* 0.28* 0.46* 0.45*
Urban 0.75* -0.24* 0.45* 0.27* 0.41* 0.43*
Non- Hispanic White 0.88* -0.29* 0.30* 0.24* 0.14* 0.10†
Non-Hispanic Blacks 0.91* -0.21* 0.32* 0.24* 0.25* 0.11‡
Mexican-Americans 0.90* -0.23* 0.37* 0.20* 0.21* 0.19*
WC Taiwanese -0.25* 0.46* 0.27* 0.43* 0.44*
Rural -0.28* 0.47* 0.28* 0.46* 0.45*
Urban -0.24* 0.45* 0.27* 0.41* 0.43*
Non- Hispanic White -0.36* 0.40* 0.32* 0.20* 0.09†
Non-Hispanic Blacks -0.27* 0.41* 0.32* 0.32* 0.18†
Mexican-Americans -0.26* 0.43* 0.25* 0.30* 0.15†
HDL Taiwanese -0.41* -0.08* -0.11* -0.12*
Rural -0.46* -0.09* -0.11* -0.12*
Urban -0.38* -0.07* -0.09* -0.12*
Non- Hispanic White -0.40* -0.18* -0.05 -0.10†
Non-Hispanic Blacks -0.32* -0.18* -0.01 -0.10‡
Mexican-Americans -0.36* -0.24* -0.06 -0.07
TG Taiwanese 0.28* 0.33* 0.34*
Rural 0.26* 0.32* 0.32*
Urban 0.28* 0.34* 0.35*
Non- Hispanic White 0.26* 0.15* 0.07‡
Non-Hispanic Blacks 0.35* 0.22* 0.14‡
Mexican-Americans 0.27* 0.23* 0.18*
FPG Taiwanese 0.28* 0.22*
Rural 0.29* 0.23*
Urban 0.27* 0.21*
Non- Hispanic White 0.24* 0.02
Non-Hispanic Blacks 0.32* 0.15‡
Mexican-Americans 0.33* 0.23*
SBP Taiwanese 0.76*
Rural 0.76*
Urban 0.77*
Non- Hispanic White 0.29*
Non-Hispanic Blacks 0.54*
Mexican-Americans 0.42*
All variables are log-transformed
Subjects with missing values of WC, HDL, TG, FPG, SBP or DBP < 30 mmHg and age less than 18 yrs old are deleted
SBP: systolic blood pressure; DBP: diastolic blood pressure
*P < 0.001
†P < 0.01
‡P < 0.05Wahlqvist et al. BMC Endocrine Disorders 2010, 10:11
http://www.biomedcentral.com/1472-6823/10/11
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Figure 1 Factor loading pairs of the MetS components from PCA after rotation for different ethnic groups.
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inputs and consequences in more systematic ways. We
would advance the view, supported by the present
enquiry into the phenomena in the US and Taiwan, that
energy dysnutrition with its environmental inputs of
energy intake and expenditure and its genomic determi-
nants are at the core of the MetS. Then, depending on the
disorder or disease which might be consequent upon it,
the ways of rounding out the syndrome, now referred to
as IER, might be several. Most usually, it is the addition of
other cardiovascular risk factors, like BP and hyperLDL/
HDLemia which have strengthened the cluster in regard
to its prediction of macrovascular disease [26,29]; or of
insulin or its sensitivity when it comes to pre-diabetes or
diabetes. Increasingly, there is interest in other connec-
tions that the MetS has with other metabolic disorders
like hyperuricaemia [24,33], inflammatory disorders [34],
hematological disorders [35] and neoplastic disorders [8].
As a matter of fact, these various linkages may also have
IER at their basis.
A somewhat similar conceptualization of the patho-
physiological basis of the MetS has been advanced by
others [36,37]. Despres and Lemieux considered that fat
maldistribution or 'dysfunctional adipose tissue' is of cen-
tral importance in the diagnosis of MetS [36]. What we
have done is, through factor analysis, found that three
components of the MetS underpin this way of thinking.
Moreover, we perceive this has been, at a more funda-
mental level, a measure of energy dysnutrition with its
associated anatomical logic in the splanchnic region.
If additional components, like insulin, are included in
the MetS definition, they will direct the unifying concept
accordingly, in this case towards insulin resistance [38].
In this way, what might constitute the basis of the insulin
resistance, such as IER, is obscured. In our analysis, we
have been able to discern a phenomenon located in less
than 6, and not more than 6, MetS components. Based on
a Caucasian twin study of metabolic risk factors (MRF)
for diabetes and cardiovascular disease, Peeters et al.
argued that a focus on MRF specific loci may be a more
useful approach to the understanding of gene-environ-
ment risk than the MetS as a whole [39]. We agree that
few MRFs may be more instructive than many and con-
sider that those components which are additional to IER
belong to various second order MRF phenomena.
While we have not formally assessed insulin resistance,
fasting glucose represents a partial measure of it, at least
insofar as nocturnal gluconeogenesis and its determina-
tion by FFA flux in the splanchnic circulation is con-
cerned. Seen this way, insulin resistance may be
embraced by the broader and unifying phenomenon of
IER.
EFA or CFA for Reconceptualisation of the Metabolic 
Syndrome?
We propose that IER components (WC, FPG, & TG)
rather than the usual six components of MetS are the
core metabolic disorder in the MetS, and have employed
an exploratory factor analysis (EFA) to differentiate the
clustering and inter-relationships among the 6 compo-
nents of MetS. As the EFA has showed, this hypothesis is
"confirmed" by the invariant (or homogeneous) pattern
across four different ethnic groups. It might be asked why
we did not employ a confirmatory factor analysis (CFA)
to confirm our hypothesis at the beginning? It is the start-
ing point for those authors who adopt the CFA approach
[38,40,41] in attempting to identify a latent structure or
factor(s) for the MetS. Our rationale was that first, since
the 3 IER components were already observed to cluster
from our datasets, we could explore them together with
the other 3 components directly and let the data speak for
themselves. Second, for those who adopted the CFA
approach, the MetS is usually accepted as the underlying
framework in their analysis; we did not want to do that,
but rather question the validity of the present MetS to
represent an integrated pathophysiological phenome-
non. Ours is an attempt to break out of the circular think-
Figure 2 Communality estimates of factor analysis across four 
ethnic groups: (a) overall; (b) by gender.
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Table 4: Proportions of variances explained by the IER and other components of the first two factors from PCA across the 
four ethnic groups: overall and by gender*
Overall
Communality
(%)
Taiwanese
(N = 5786)
Non-Hispanic White
(N = 1248)
Non-Hispanic Black
(N = 457)
Mexican-American
(N = 549)
Absolute Relative Absolute Relative Absolute Relative Absolute Relative
logSBP+logDBP 26.8
(26.1, 27.3)
42.0
(41.0, 43.0)
20.1
(18.5, 21.7)
36.5
(33.7, 38.9)
24.5
(22.5, 26.0)
41.2
(38.1, 44.2)
22.0
(20.1, 23.6)
38.4
(35.2, 41.0)
logHDL 12.4
(11.7, 12.9)
19.5
(18.5, 20.2)
9.7
(8.6, 10.8)
17.7
(15.5, 19.5)
8.7
(6.2, 10.8)
14.7
(10.7, 18.0)
10.0
(8.1, 11.7)
17.4
(14.2, 20.2)
logWC+logFPG+logTG 24.6
(24.0, 25.2)
38.5
(37.9, 39.2)
25.3
(24.3, 26.7)
45.8
(44.2, 47.8)
25.9
(24.5, 28.1)
43.9
(41.7, 46.7)
25.3
(23.5, 27.9)
44.2
(41.6, 48.1)
Factor1+Factor2 63.7
(63.0, 64.5)
100 55.2
(53.9, 57.0)
100 59.1
(57.0, 61.8)
100 57.5
(55.2, 59.8)
100
Male
Communality
(%)
Taiwanese
(N = 2827)
Non-HispanicWhite
(N = 602)
Non-Hispanic Black
(N = 226)
Mexican-American
(N = 266)
Absolute Relative Absolute Relative Absolute Relative Absolute Relative
logSBP+logDBP 26.6
(25.9, 27.3)
43.4
(42.2, 44.5)
20.1
(17.5, 21.8)
37.3
(32.5, 39.8)
24.2
(20.3,26.7)
41.3
(34.6,45.0)
18.8
(15.8, 21.4)
32.8
(27.7, 36.3)
logHDL 11.5
(10.8, 12.1)
18.7
(17.6, 19.6)
9.8
(7.9, 12.2)
18.1
(14.6, 22.6)
9.5
(5.5, 12.8)
16.1
(9.4, 21.3)
13.4
(11.7, 14.2)
23.1
(19.9, 24.6)
logWC+logFPG+logTG 23.3
(22.4, 24.3)
37.9
(37.0, 39.0)
24.0
(22.2, 27.2)
44.5
(41.6, 49.3)
25.0
(23.3,28.6)
42.6
(40.0,47.7)
25.8
(23.7, 28.9)
44.1
(41.8, 48.9)
Factor1+Factor2 61.3
(60.4, 62.4)
100 53.9
(52.3, 56.7)
100 58.7
(55.6,62.9)
100 58.0
(55.1, 61.5)
100
Female
Communality
(%)
Taiwanese
(N = 2959)
Non-HispanicWhite
(N = 646)
Non-Hispanic Black
(N = 231)
Mexican-American
(N = 283)
Absolute Relative Absolute Relative Absolute Relative Absolute Relative
logSBP+logDBP 25.7
(24.9, 26.5)
41.2
(39.7, 42.5)
19.1
(16.9, 21.5)
34.5
(30.4, 37.8)
24.2
(22.2, 26.2)
39.8
(36.0, 43.7)
23.7
(21.7, 25.3)
40.6
(37.4, 43.5)
logHDL 12.4
(11.2, 13.4)
19.8
(17.9, 21.4)
8.5
(7.0, 10.0)
15.4
(12.5, 17.8)
9.0
(5.5, 11.6)
14.8
(9.4, 18.4)
7.2
(4.2, 9.8)
12.3
(7.4, 16.6)
logWC+logFPG+logTG 24.4
(23.3, 25.6)
39.1
(37.8, 40.4)
27.9
(26.5, 30.2)
50.2
(47.6, 53.3)
27.5
(25.6, 30.3)
45.4
(42.9, 49.0)
27.4
(24.5, 31.1)
47.1
(42.6, 52.9)
Factor1+Factor2 62.5
(61.4, 63.7)
100 55.6
(54.2, 58.3)
100 60.7
(57.8, 64.7)
100 58.2
(55.6, 61.6)
100
* The numbers in parentheses are the 95% CIs obtained from 1000 bootstrap resamplingsWahlqvist et al. BMC Endocrine Disorders 2010, 10:11
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ing which has limited MetS research, in our view, and to
search for a novel phenotype. Third, our paper attempts
to re-conceptualize the MetS. It was therefore inappro-
priate to manipulate the datasets in accordance with a
hypothesis and then test for it. Hence, we used an explor-
atory rather than a confirmatory approach.
As indicated, the conceptual IER segregates from the
rest of the components of the MetS and provides a unify-
ing capacity with which to consider inputs and conse-
quences in more systematic ways. Greater sophistication
in our hypothesis would involve reference to insinuated,
but unobserved measurements (such as free fatty acid) or
latent or partially captured factors (such as insulin resis-
tance), at which point the CFA approach would be appro-
priate. Our findings provide a near-fundamental basis
with which to take IER further through more structured
hypotheses about phenotype, cellular biology and
genomics. Such an enquiry would have public health and
clinical relevance.
Relation of the IER to other MetS components
The extent to which the non-IER MetS components and
their health outcome significance differ between the eth-
nic groups studied is of interest We have noted in the
results that, for Taiwan, the BP cluster is closer to the IER
cluster than in the US ethnic populations. Furthermore,
in the case of diastolic BP, where Taiwan has the highest
values and prevalence, it is against a background of pref-
erence for a high Na/K molar ratio diet, and relatively
high incidence of hemorrhagic stroke as featured in the
annual Public Health reports. On the other hand, rela-
tively greater North American lipoprotein cholesterol
abnormalities (Tables 1 and 2) appear to accentuate the
risk for atherosclerotic macrovascular disease amongst
the 3 relevant ethnic groups in this study, as judged from
other evidence. On the other hand, in at least some popu-
lations, the ability of the MetS to predict clinical out-
comes of diabetes and cardiovascular disease is widely
divergent, as in elderly Europeans where the prediction of
the former greater exceeded that of the latter [42]. This
would lend support to the notion that the impact of the
IER MetS components might or might not depend on the
non-IER MetS components and other factors.
A more analytical study of the representative Taiwanese
subjects by age, gender and locality provides further
insights into the core and second order of the MetS com-
ponents (Table 5 and figure 3). With regard to age, most
components (WC, glucose, triglycerides, SBP and DBP),
except HDL cholesterol, are more compromised in older
individuals, whether men or women, or whether urban or
rural. However, the core continues to behave in a coher-
ent way (Figure 3), except in older urban women where 3
factors emerge.
Pathophysiology
Our segregation of the MetS into an energy-dependent
core (IER) and other phenomena is consistent with
emerging evidence on the regulation of cellular fuel
metabolism and about mitochondrial function and disor-
der. In particular, the AMP-activated protein kinase cas-
cade has been identified as a unifying system for energy
control by Carling and others [43]. It also is involved in
insulin signaling [44] and senses glycogen stores [45].
Another possibility which has been proposed by Bhopal
and Rafnssson is that mitochondrial efficiency might
explain susceptibility to adiposity and the metabolic syn-
drome, which is to say that ATP and heat generation
might be involved, perhaps through mitochondrial DNA
mutations characteristic of certain populations [46].
Since, in absolute values, our IER components are lower
in Taiwanese than in any of the US populations, this is a
difference which could represent mitochondrial effi-
ciency differences. Aside from the likely pivotal role of
exercise and energy intake in the modulation of IER as for
the MetS itself [46], it may offer new approaches in the
treatment of metabolic disorders [47]. Linked to this will
be the integrity of mitochondrial energy metabolism and
function [48,49].
Health status of subjects
In both the US and Taiwan, the study populations were
community-based and representative, not selected for
health status and not institutionalised in this cross-sec-
tional study. Their health characteristics are shown in
part, by reported behaviours (eg tobacco smoking) and
various risk factors, by the medication history, by anthro-
pometry to detect body fatness and its distribution and
by virtue of the components of the MetS itself. Although
physical activity and alcohol intake were recorded, the
frequency of missing values in the US ethnic groups pre-
cluded their reliable evaluation.
Figure 3 Communality estimates of factor analysis across urban 
and rural Taiwanese by gender and age strata.
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Table 5: Age-specific comparisons of the MetS components of Taiwanese with different urbanization status
< 35 yr 35-64 yr 65 + yr
Variables Urban Rural Urban Rural Urban Rural
All N = 1246 N = 769 N = 2056 N = 1112 N = 348 N = 255
Age (years) 26.0 ± 5.2 26.2 ± 5.1 47.1 ± 7.8 47.6 ± 8.3 72.3 ± 5.3 72.7 ± 5.7
WC (cm) 75.3 ± 11.0 75.4 ± 11.0 80.8 ± 10.8 81.9 ± 10.6 * 85.5 ± 9.9 85.0 ± 9.5
Glucose (mg/dl) 85.3 ± 13.4 87.0 ± 12.5 * 95.1 ± 28.5 99.3 ± 33.9 * 102.5 ± 33.7 104.6 ± 35.5
Triglycerides(mg/dl) 99.9 ± 59.5 111.2 ± 70.7 * 133.7 ± 86.8 142.6 ±100.3 * 142.4 ± 77.2 149.1 ± 92.3
HDL (mg/dl) 54.7 ± 12.6 53.4 ± 13.3 56.9 ± 15.8 55.4 ± 15.4 * 56.1 ± 15.8 54.0 ± 15.9
LDL (mg/dl) 102.6 ± 23.4 107.8 ± 24.5 * 120.0 ± 26.3 120.7 ± 26.6 126.3 ± 27.4 123.4 ± 28.3
Total Cholesterol(mg/dl) 166.3 ± 31.5 171.2 ± 32.6 * 190.3 ± 36.3 190.1 ± 36.1 196.5 ± 36.9 191.4 ± 39.5
SBP (mm Hg) 105.7 ± 11.8 107.8 ± 12.3 * 115.3 ± 16.9 118.6 ± 17.2 * 133.2 ± 18.7 133.1 ± 18.3
DBP (mm Hg) 70.0 ± 9.4 71.0 ± 9.6 * 76.7 ± 11.4 77.6 ± 11.5 * 78.1 ± 10.8 78.3 ± 10.9
BMI (kg/m2) 21.9 ± 3.6 22.3 ± 3.8 * 23.7 ± 3.3 24.0 ± 3.6 * 23.8 ± 3.2 23.4 ± 3.1
Weight (Kg) 60.3 ± 12.5 60.4 ± 12.8 62.2 ± 11.1 62.8 ± 11.3 61.6 ± 10.0 60.5 ± 9.7
Height (cm) 165.4 ± 8.1 164.2 ± 8.0 * 161.7 ± 7.7 161.4 ± 7.6 160.8 ± 8.4 160.7 ± 7.9
HT drug (%) 0.2 0 7.6 7.8 32.8 33.7
DM drug (%) 0.2 0 3.4 3.8 12.1 11.4
Lipid drug (%) 0.08 0.13 2.0 1.5 5.7 6.7
Current smokers ¥ (%) 16.9 17.8 20.2 24.1 * 17.8 25.9 *
Males N = 611 N = 360 N = 942 N = 559 N = 193 N = 162
Age (years) 25.7 ± 5.2 25.9 ± 5.2 47.2 ± 7.8 47.7 ± 8.5 72.6 ± 5.1 72.7 ± 5.4
WC (cm) 80.5 ± 10.9 80.7 ± 10.9 86.1 ± 9.9 86.2 ± 9.6 86.9 ± 10.2 86.6 ± 8.8
Glucose (mg/dl) 86.8 ± 15.5 87.5 ± 14.6 96.6 ± 32.3 100.2 ± 34.0 99.5 ± 27.4 103.8 ± 35.8
Triglycerides(mg/dl) 114.1 ± 68.0 132.5 ± 85.6 * 156.1 ± 98.9 164.4 ± 114.7 * 135.6 ± 72.0 148.4 ± 92.5
HDL (mg/dl) 51.5 ± 12.3 49.5 ± 13.0 * 52.2 ± 15.4 51.2 ± 15.5 53.4 ± 15.4 51.0 ± 15.6
LDL (mg/dl) 106.1 ± 25.5 109.3 ± 25.1 122.4 ± 25.4 121.2 ± 26.2 123.4 ± 26.3 121.2 ± 27.5
Total Cholesterol (mg/dl) 168.1 ± 34.4 170.8 ± 33.0 190.5 ± 34.2 188.7 ± 36.1 189.9 ± 34.1 186.0 ± 38.7
SBP (mm Hg) 111.5 ± 11.1 114.1 ± 11.3 * 118.4 ± 16.3 121.2 ± 16.7 * 132.2 ± 16.6 133.3 ± 18.9
DBP (mm Hg) 73.9 ± 8.9 74.9 ± 9.4 80.0 ± 11.1 80.2 ± 11.5 78.2 ± 10.6 79.1 ± 11.4
BMI (kg/m2) 22.9 ± 3.7 23.4 ± 3.9 * 24.3 ± 3.2 24.4 ± 3.1 23.3 ± 2.9 23.4 ± 2.8
Weight (Kg) 67.5 ± 11.9 68.1 ± 12.0 68.5 ± 10.1 67.9 ± 10.2 64.6 ± 9.9 63.7 ± 8.3
Height (cm) 171.5 ± 5.9 170.5 ± 5.7 * 167.7 ± 5.7 166.8 ± 5.7 * 166.3 ± 5.9 165.0 ± 5.3 *
HT drug (%) 0.3 0 7.0 7.2 33.7 36.4
DM drug (%) 0.3 0 3.6 4.3 13.5 9.3
Lipid drug (%) 0.2 0.3 2.0 1.3 5.2 5.6
Current smokers ¥ (%) 31.4 35.8 40.3 46.0 30.6 38.3Wahlqvist et al. BMC Endocrine Disorders 2010, 10:11
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The interpretation of the medication use is difficult.
First, it is some confirmation of a risk or disease state eg
hypertension, hyperlipidaemia or diabetes. Second, it
means the observed MetS components will have been
somewhat corrected depending on compliance, afford-
ability, access to health care and public health education.
In these respects the US and Taiwan are strikingly differ-
ent, since Taiwan has a universal health insurance scheme
(which includes pharmaceuticals), with 99% of the popu-
lation covered, and the US does not. Nevertheless, in
both places, remoteness, culture, education, socio-eco-
nomic circumstances and other equity issues are likely to
have influenced MetS component profiles. For example,
our data showed age and gender might have effects on
MetS, especially on urban older women. Notwithstanding
these considerations, the MetS core is robust by setting,
health status and where other differences will be inevita-
ble.
Public health and clinical implications
If the MetS can be understood in clearer etiologic and
pathogenetic terms, it will pave the way for more rational
and supportable public health preventive strategies and
clinical interventions.
It remains unclear as to how important the MetS is in
the prediction of morbidity and mortality in different
clinical settings and the understanding of IER may clarify
this situation. From the public health point of view, the
"physical activity transition" and its role in the genesis of
MRFs as proposed by Katzmarzyk and Mason may oper-
ate principally through the IER pathway [46].
Conclusions
Energy dysnutrition is a fundamental problem at all
stages of economic development. It may operate at differ-
ent levels from the environmental-human biology inter-
face to every human cell, in turn to determine the
likelihood of health and well-being. However, in public
health and clinical practice, its measurement is available,
not only by way of intake and expenditure with difficulty,
but also by way of waist (or abdominal) circumference for
abdominal fat stores and by fasting plasma glucose and
triglycerides as fuels generated in the splanchnic circula-
tion and region. These 3 components (IER) of the MetS
cluster consistently across several ethnic groups in differ-
ent localities; nevertheless, the phenomenon is not as
pronounced in Taiwan as the US and its persistence into
later life is less evident in urban Taiwanese women The
IER cluster allows a step-wise first (core) and then second
order approach to the understanding and application of
the present form of the MetS, in relation to cardiovascu-
l a r  d i s e a s e .  T h i s  a l s o  a l l o w s  f o r  o t h e r  v a r i a n t s  o f  t h e
MetS, more relevant, for example, to inflammatory or
neoplastic disease, to be developed as second order phe-
nomena. We are encouraged to take advantage of these
findings in cohort and intervention studies, especially
Females N = 635 N = 409 N = 1114 N = 553 N = 155 N = 93
Age (years) 26.2 ± 5.2 26.4 ± 5.1 47.1 ± 7.9 47.5 ± 8.1 71.8 ± 5.6 72.8 ± 6.2
WC (cm) 70.3 ± 8.7 70.7 ± 8.8 76.3 ± 9.4 77.5 ± 9.8 * 83.6 ± 9.2 82.2 ± 10.1
Glucose (mg/dl) 83.9 ± 10.7 86.5 ± 10.3 * 93.8 ± 24.7 98.4 ± 33.7 * 106.2 ± 40.0 105.8 ± 35.0
Triglycerides (mg/dl) 86.3 ± 46.0 92.5 ± 47.0 * 114.8 ± 69.8 120.4 ± 77.1 150.8 ± 82.7 150.4 ± 92.3
HDL (mg/dl) 57.7 ± 12.1 56.8 ± 12.7 * 60.9 ± 14.9 59.6 ± 14.1 59.4 ± 15.7 59.3 ± 15.0
LDL (mg/dl) 99.3 ± 20.7 106.5 ± 24.0 118.0 ± 26.9 120.3 ± 27.0 129.9 ± 28.5 127.2 ± 29.3
Total Cholesterol (mg/dl) 164.5 ± 28.3 171.5 ± 32.3 * 190.2 ± 37.9 191.6 ± 36.1 204.6 ± 38.8 200.9 ± 39.4
SBP (mm Hg) 100.1 ± 9.6 102.2 ± 10.3 * 112.7 ± 17.1 115.9 ± 17.3 * 134.4 ± 21.0 132.7 ± 17.5
DBP (mm Hg) 66.3 ± 8.2 67.6 ± 8.4 * 73.8 ± 10.8 75.0 ± 10.8 * 77.8 ± 11.0 76.8 ± 9.7
BMI (kg/m2) 21.0 ± 3.2 21.3 ± 3.6 23.2 ± 3.4 23.7 ± 4.0 * 24.4 ± 3.5 23.5 ± 3.7 *
Weight (Kg) 53.4 ± 8.6 53.6 ± 9.2 56.8 ± 8.7 57.6 ± 9.9 57.8 ± 8.6 55.0 ± 9.5 *
Height (cm) 159.5 ± 5.0 158.5 ± 4.9 * 156.6 ± 5.0 155.9 ± 4.8 * 154.0 ± 5.6 153.0 ± 5.6
HT drug (%) 0 0 8.2 8.5 31.6 29.0
DM drug (%) 0 0 3.2 3.3 10.3 15.1
Lipid drug (%) 0 0 2.0 1.8 6.5 8.6
Current smokers ¥ (%) 3.0 2.0 3.1 2.0 1.9 4.3
† At significant level α = 0.05, p-value < 0.05 (*) was used for two-sample t-test were used for comparing means between urban and rural 
Taiwanese in each gender and age-specific strata.
¥ Current smokers were considered to subjects who have a life-time smoking experience of ≥ 100 cigarettes and currently smoke
Table 5: Age-specific comparisons of the MetS components of Taiwanese with different urbanization status (Continued)Wahlqvist et al. BMC Endocrine Disorders 2010, 10:11
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those which include genetic markers for energy metabo-
lism, fat distribution, and various clinical outcomes.
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